|
|
|
Insider
Information: |
Graham Ginger L |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
141,600 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$34,637 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
141,600 |
|
|
Total
Value |
$34,637 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2009-03-18 |
139,450 |
2005-01-04 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director |
2011-04-01 |
0 |
2019-11-08 |
0 |
Premium* |
|
Walgreens Boots Alliance, Inc. |
WBA |
Director |
2017-10-26 |
2,150 |
2017-10-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMLN |
Amylin Pharmaceuticals In... |
President and Chief Executive |
|
2006-06-09 |
4 |
OE |
$16.54 |
$249,981 |
D/D |
10,869 |
141,496 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President and Chief Executive |
|
2005-05-06 |
4 |
B |
$16.65 |
$199,800 |
D/D |
12,000 |
118,535 |
2.74 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2018-08-06 |
4 |
OE |
$17.33 |
$285,945 |
I/I |
16,500 |
26,756 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Executive Advisor |
|
2007-08-08 |
4 |
AS |
$51.11 |
$1,183,598 |
D/D |
(23,000) |
147,523 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Executive Advisor |
|
2007-08-08 |
4 |
OE |
$9.16 |
$337,250 |
D/D |
23,000 |
155,523 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2018-12-11 |
4 |
OE |
$14.37 |
$476,438 |
I/I |
24,750 |
51,648 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President and Chief Executive |
|
2005-01-04 |
4 |
OE |
$7.13 |
$213,750 |
D/D |
30,000 |
105,600 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2019-11-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(53,304) |
0 |
0 |
- |
|
58 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|